<?xml version="1.0" encoding="UTF-8"?>
<p id="p0379" num="0379" sourceFile="EP 1326865B1.xml">The title compound was prepared using the procedure described in Example 1, Step 3 replacing methyl 8-hydroxy-1,6-naphthyridine-7-carboxylate with methyl 8-[(4-methoxybenzyl)oxy]-5-(2-thienyl)-1,6-naphthyridine-7-carboxylate from Step 3.
  <br/>
  <sup>1</sup>H NMR (CDCl
  <sub>3</sub>, 400MHz) δ 13.09 (1H, s), 9.25 (1H, d, 
  <i>J</i>=4.2Hz), 8.80 (1H, d, J=8.8Hz), 8.47 (1H, t, 
  <i>J</i>=6.0 Hz), 7.71 (1H, dd, 
  <i>J</i>=8.7 and 4.3 Hz), 7.54 (1H, t, 
  <i>J</i>=6.2Hz), 7.47 (1H, d, J=3.6Hz), 7.35-7.15 (4H, m), 4.68 (2H, d, 
  <i>J</i>=6.5 Hz) ppm.
  <br/> FAB MS calcd for C
  <sub>20</sub>H
  <sub>13</sub>N
  <sub>3</sub>O
  <sub>2</sub> S 430 (MH
  <sup>+</sup>), found 430.
  <br/> FAB HRMS exact mass calc'd for C
  <sub>20</sub>H
  <sub>13</sub>N
  <sub>3</sub>O
  <sub>2</sub> S 430.0179 (MH
  <sup>+</sup>), found 430.0192.
</p>
